SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Provost, T.
Right arrow Articles by Simmons-O'Brien, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Provost, T.
Right arrow Articles by Simmons-O'Brien, E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Joint Disorders
*Salivary Gland Disorders
*Sjogren's Syndrome
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anti-Ro(SS-A) antibody positive Sjögren's/lupus erythematosus overlap syndrome

TT Provost

The Johns Hopkins University School of Medicine, Department of Dermatology, Baltimore, Maryland

R. Watson

St. James Hospital, Dublin, Ireland

E. Simmons-O'Brien

The Johns Hopkins University School of Medicine, Baltimore, Maryland

Unlike anti-Ro(SS-A) antibody positive subacute cutaneous lupus erythematosus (SCLE) patients, anti-Ro(SS-A) antibody positive lupus patients with Sjögren's syndrome (SS/LE) appear to have a more guarded prognosis. Our studies indicate these SS/LE patients have an increased frequency of pulmonary, neurological, and renal disease compared to SCLE patients.

Key Words: Sjögren's syndrome • lupus erythematosus • anti-Ro(SS-A) antibodies • renal • neurologic and pulmonary disease

Lupus, Vol. 6, No. 2, 105-111 (1997)
DOI: 10.1177/096120339700600205
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
A N Scofield, B T Kurien, T P Gordon, and R H Scofield
Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjogren's syndrome?
Lupus, August 1, 2001; 10(8): 547 - 553.
[Abstract] [PDF]


Advertisement